Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Ireland, shared a post on X:
“My ELCC25 Top 3:
1. MARIPOSA: meets OS (HR 0.75), but tox burden limits to a subset of patients? Controversial
2. KRYSTAL7: mPFS 27.7m. Way better than I expected. One to watch
3. Deescalation trials by Benjamin Besse. Let’s be good oncologists, and good citizens
Thanks ESMO.”
